2022
DOI: 10.1007/s11010-022-04434-z
|View full text |Cite
|
Sign up to set email alerts
|

Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“… 65 The U 2 OS tumor cell line, first isolated from a sarcoma case in 1964, is a widely used cell line model in the pathogenesis of osteosarcoma. 66 Administration of 35 mg/kg/day of acrylamide by gastric gavage for 2 weeks to adult male rats resulted in a significant increase in serum TNF-α and leptin levels in the rats, compared with the control group. 67 Increased leptin levels in the blood (hyperleptinemia), observed as a comorbidity of obesity, 68 is associated with adipose tissue inflammation.…”
Section: Development Of the Obesogen Hypothesismentioning
confidence: 94%
“… 65 The U 2 OS tumor cell line, first isolated from a sarcoma case in 1964, is a widely used cell line model in the pathogenesis of osteosarcoma. 66 Administration of 35 mg/kg/day of acrylamide by gastric gavage for 2 weeks to adult male rats resulted in a significant increase in serum TNF-α and leptin levels in the rats, compared with the control group. 67 Increased leptin levels in the blood (hyperleptinemia), observed as a comorbidity of obesity, 68 is associated with adipose tissue inflammation.…”
Section: Development Of the Obesogen Hypothesismentioning
confidence: 94%
“…These endogenous promoters are often used for high-efficiency expression of recombinant proteins and also be applied to the expression of Cas9 protein with the rise of the CRISPR/Cas9 system [ 25 ]. Moreover, in the expression of relevant elements of the CRISPR/Cas9 system, the strong Pol II promoter can also be used for the expression of resistance genes or marker genes, which ensures that the gene-edited monoclonal cells can be filtered for genetic researches by antibiotic treatment [ 26 ] or flow cytometry [ 27 ].…”
Section: Introductionmentioning
confidence: 99%